BR112012004945A2 - bacteriófago novo e composição antibacteriana compreendendo o mesmo - Google Patents
bacteriófago novo e composição antibacteriana compreendendo o mesmoInfo
- Publication number
- BR112012004945A2 BR112012004945A2 BR112012004945A BR112012004945A BR112012004945A2 BR 112012004945 A2 BR112012004945 A2 BR 112012004945A2 BR 112012004945 A BR112012004945 A BR 112012004945A BR 112012004945 A BR112012004945 A BR 112012004945A BR 112012004945 A2 BR112012004945 A2 BR 112012004945A2
- Authority
- BR
- Brazil
- Prior art keywords
- salmonella
- novel bacteriophage
- same
- antibacterial composition
- bacteria
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
''bacteriófago novo e composição antibacterana compreendendo o mesmo'' está revelado neste um bacteriófago novo que tem uma atividade específica contra uma ou mais bactérias salmonella selecionadas do grupo consistindo em salmonella enteritidis, salmonella typhimurium, salmonella gallinarum, e salmonella pullorum sem afetar bactérias benéficas. também estão revelados neste, composições, ração animal ou água para beber, limpadores e desinfetantes para prevenção e tratamento de doenças infecciosas causadas por salmonella enteritidis, salmonella typhimurium, salmonella gallinarum ou salmonella pullorum incluindo salmonelose, intoxicação alimentar por salmonella, tifo aviário e pulorose ou para controlar as bactérias de salmonela.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23974809P | 2009-09-03 | 2009-09-03 | |
US61/239,748 | 2009-09-03 | ||
PCT/KR2010/005999 WO2011028059A2 (en) | 2009-09-03 | 2010-09-03 | Novel bacteriophage and antibacterial composition comprising the same |
Publications (3)
Publication Number | Publication Date |
---|---|
BR112012004945A2 true BR112012004945A2 (pt) | 2017-07-18 |
BR112012004945B1 BR112012004945B1 (pt) | 2020-11-17 |
BR112012004945B8 BR112012004945B8 (pt) | 2021-05-25 |
Family
ID=43625259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012004945A BR112012004945B8 (pt) | 2009-09-03 | 2010-09-03 | composição para prevenção ou tratamento de doenças infecciosas, comida para animal ou água potável,sanitizante e produto de limpeza |
Country Status (7)
Country | Link |
---|---|
US (1) | US8329442B2 (pt) |
EP (1) | EP2475377B1 (pt) |
JP (1) | JP5613767B2 (pt) |
CN (1) | CN102596219B (pt) |
BR (1) | BR112012004945B8 (pt) |
ES (1) | ES2562640T3 (pt) |
WO (1) | WO2011028059A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201114104D0 (en) * | 2011-08-17 | 2011-09-28 | Univ Nottingham | Salmonella phage |
PL217019B1 (pl) | 2011-08-25 | 2014-06-30 | Proteon Pharmaceuticals Spółka Akcyjna | Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie |
KR101432872B1 (ko) * | 2011-09-20 | 2014-08-27 | 씨제이제일제당 (주) | 신규 박테리오파지 및 이를 포함하는 항균 조성물 |
EP2781220A1 (en) * | 2013-03-18 | 2014-09-24 | PTC Phage Technology Center GmbH | Bacteriophages against Salmonella and their use |
JP6112961B2 (ja) * | 2013-05-09 | 2017-04-12 | サラヤ株式会社 | サルモネラ属菌に対して溶菌性を示す新規バクテリオファージ、及びそれを含有する組成物 |
KR101591789B1 (ko) * | 2014-04-15 | 2016-02-04 | 씨제이제일제당(주) | 신규 박테리오파지 및 이를 포함하는 조성물 |
US11058131B2 (en) | 2015-04-16 | 2021-07-13 | Kennesaw State University Research And Service Foundation, Inc. | Escherichia coli O157:H7 bacteriophage Φ241 |
CN109666654B (zh) * | 2015-06-09 | 2022-05-31 | 菲吉乐科(南京)生物科技有限公司 | 新的噬菌体、其组合物以及它们的制备方法和应用 |
WO2017089947A2 (es) | 2015-11-25 | 2017-06-01 | Universidad De Los Andes | Composición que comprende bacteriófagos para reducir, eliminar y/o prevenir salmonella enteritidis, salmonella typhimurium y salmonella paratyphi b |
CN108220249A (zh) * | 2016-12-12 | 2018-06-29 | 上海交通大学医学院附属第九人民医院 | 长尾噬菌体及其获得方法和应用 |
KR102016919B1 (ko) * | 2016-12-23 | 2019-09-02 | 주식회사 옵티팜 | 신규한 살모넬라균 특이 박테리오파지 sc1 및 이를 포함하는 항균 조성물 |
CN108359644B (zh) * | 2018-02-07 | 2019-08-02 | 青岛诺安百特生物技术有限公司 | 一种宽谱沙门氏菌噬菌体及其应用 |
CN108707185B (zh) * | 2018-05-24 | 2022-02-11 | 华南理工大学 | 一种延长噬菌体血液循环时间的多肽 |
WO2019227266A1 (zh) * | 2018-05-28 | 2019-12-05 | 华南理工大学 | 一种延长噬菌体血液循环时间的多肽 |
CN111254121B (zh) * | 2020-03-10 | 2022-03-18 | 青岛诺安百特生物技术有限公司 | 一种沙门氏菌噬菌体及在防治沙门氏菌感染的疾病的药物中的应用 |
CN112795544B (zh) * | 2021-02-05 | 2022-08-12 | 山东仙普爱瑞科技股份有限公司 | 一株跨属烈性噬菌体、制备工艺及其在防治猪副伤寒和鸡白痢的应用 |
CN113230283A (zh) * | 2021-04-01 | 2021-08-10 | 石河子大学 | 一种鸡大肠杆菌治疗性微生态制剂及其制备与应用 |
CN113980914B (zh) * | 2021-12-06 | 2024-05-10 | 青岛新万福食品有限公司 | 一种宽裂解谱噬菌体及其在肉类冷冻保鲜中的应用 |
WO2024025936A2 (en) * | 2022-07-26 | 2024-02-01 | Board Of Trustees Of Michigan State University | Development of carbohydrate-based anti-salmonella vaccines |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000508322A (ja) | 1996-04-15 | 2000-07-04 | エヌワイエムオーエックス コーポレーション | バクテリオファージを含有する組成物および感染症を治療するためのバクテリオファージの使用方法 |
US6485902B2 (en) | 2000-06-06 | 2002-11-26 | Thomas E. Waddell | Use of bacteriophages for control of escherichia coli O157 |
US20070054357A1 (en) * | 2005-09-06 | 2007-03-08 | Pasternack Gary R | Identification of useful bacteriophage |
KR100941891B1 (ko) * | 2007-09-20 | 2010-02-16 | 주식회사 인트론바이오테크놀로지 | 살모넬라 엔테리티디스 감염 박테리오파지로부터 선별된살모넬라 특이적 사멸능을 갖는 신규한 박테리오파지 |
KR100943041B1 (ko) * | 2007-09-20 | 2010-02-19 | 재단법인서울대학교산학협력재단 | 시포비리대에 속하는 박테리오파지 및 이를 포함하는 세균사멸용 조성물 |
KR101151532B1 (ko) * | 2008-12-24 | 2012-05-30 | 씨제이제일제당 (주) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 |
KR101151516B1 (ko) * | 2008-12-24 | 2012-05-30 | 씨제이제일제당 (주) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 |
-
2010
- 2010-09-03 CN CN201080042733.1A patent/CN102596219B/zh active Active
- 2010-09-03 US US12/876,016 patent/US8329442B2/en active Active
- 2010-09-03 EP EP10813968.4A patent/EP2475377B1/en active Active
- 2010-09-03 BR BR112012004945A patent/BR112012004945B8/pt active IP Right Grant
- 2010-09-03 JP JP2012527830A patent/JP5613767B2/ja active Active
- 2010-09-03 WO PCT/KR2010/005999 patent/WO2011028059A2/en active Application Filing
- 2010-09-03 ES ES10813968.4T patent/ES2562640T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP2475377A4 (en) | 2013-06-26 |
JP2013503628A (ja) | 2013-02-04 |
CN102596219B (zh) | 2014-04-30 |
JP5613767B2 (ja) | 2014-10-29 |
BR112012004945B8 (pt) | 2021-05-25 |
US20110052544A1 (en) | 2011-03-03 |
WO2011028059A3 (en) | 2011-07-14 |
EP2475377A2 (en) | 2012-07-18 |
ES2562640T3 (es) | 2016-03-07 |
CN102596219A (zh) | 2012-07-18 |
BR112012004945B1 (pt) | 2020-11-17 |
EP2475377B1 (en) | 2016-01-06 |
US8329442B2 (en) | 2012-12-11 |
WO2011028059A2 (en) | 2011-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012004945A2 (pt) | bacteriófago novo e composição antibacteriana compreendendo o mesmo | |
BRPI0902901B8 (pt) | bacteriófago e composição antibacteriana, alimento para animais, água potável, desinfetante, agente de limpeza e método para tratamento de doenças infecciosas compreendendo o mesmo | |
BR112013015635A2 (pt) | bacteriófago isolado, composição e método de antibiótico para prevenção ou tratamento de doenças infecciosas causadas por uma ou mais linhagens de salmonella, alimentação animal ou água potável e desinfetante ou limpador | |
BR112013004206A2 (pt) | novo bacteriófago isolado contendo atividade bactericida específica de e. coli e composição antibacteriana que compreende o mesmo | |
BR112014006768A2 (pt) | novo bacteriófago e composição antibacteriana compreendendo o mesmo | |
WO2011028057A3 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
UA111464C2 (uk) | Композиція, що містить моногліцериди органічних кислот c1-c7 та гліцерин, та її застосування як протибактеріального та протипліснявого засобу | |
BR112017014649A2 (pt) | ?isolado intestinal humano, e, composição? | |
BR112012032877A2 (pt) | uso de ácido chicórico e derivados para regulagem de pigmentação da pele | |
BR112012007598A2 (pt) | composição para promoção da produção de colágeno | |
PE20141452A1 (es) | Cepas de salmonella gallinarum modificadas avirulentas y composiciones farmaceuticas que las usan | |
BR112018008781A2 (pt) | agente antimicrobiano compreendendo xantohumol e o uso do mesmo em produtos alimentícios | |
BR112017004933A2 (pt) | composição de limpeza antimicrobiana e método de limpeza ou desinfecção de uma superfície | |
WO2011028061A3 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
MX369176B (es) | Composiciones fitoquímicas útiles como desinfectantes y conservadores para alimentos. | |
WO2011028064A3 (en) | Novel bacteriophage and antibacterial composition comprising the same | |
BR112013005532A2 (pt) | agente terapêutico para dor | |
TR200900881A2 (tr) | Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler | |
CL2015001254A1 (es) | Composición quelante de arsénico. | |
BR112016014981A2 (pt) | Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina | |
MX2010009311A (es) | Composiciones desinfectantes. | |
BR112018007213A2 (pt) | composto, formulação de fragrância, métodos para melhorar, intensificar ou modificar uma formulação de fragrância e para neutralizar odor desagradável, e, produto de fragrância. | |
BR112015027837A2 (pt) | Combinação de extratos de planta usada como um aditivo para ração | |
CN103689003A (zh) | 一种杀菌剂 | |
BR112014017448A2 (pt) | composição dermocosmética contendo como princípio ativo, uma combinação sinérgica de prata coloidal e ácido desoxirribonucleico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/09/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |